Keyphrases
Meta-analysis
100%
Systematic Meta-analysis
100%
Safety Profile
100%
Hematological Malignancies
100%
Efficacy Profile
100%
Patients with Hematological Malignancies
100%
COVID-19 mRNA Vaccine
100%
Healthy Controls
50%
Antibody Titer
33%
Patient Demographics
33%
Seroconversion Rate
33%
Immunological Response
16%
Adverse Effects
16%
Seroconversion
16%
Malignancy
16%
Low Dose Rate
16%
Subgroup Analysis
16%
Two-dose
16%
Non-Hodgkin Lymphoma
16%
Booster Dose
16%
Active Treatment
16%
Response to COVID-19
16%
COVID-19 Vaccine
16%
Health Protocol
16%
Quantitatively Analysis
16%
Quantitative Synthesis
16%
COVID-19 Vaccination
16%
Response to Vaccination
16%
Medicine and Dentistry
Meta-Analysis
100%
Systematic Review
100%
Hematologic Malignancy
100%
COVID-19
100%
mRNA Vaccine
100%
Seroconversion
33%
Patient Population
22%
Cancer
11%
Adverse Event
11%
Subgroup Analysis
11%
Non-Hodgkin Lymphoma
11%
Single Drug Dose
11%
COVID-19 Vaccination
11%
COVID-19 Vaccine
11%
Booster Dose
11%
Immunology and Microbiology
Vaccine Efficacy
100%
COVID-19
100%
Seroconversion
42%
Antibody Titer
28%
Vaccination Policy
28%
Normal Human
14%
Booster Dose
14%
Biochemistry, Genetics and Molecular Biology
Messenger RNA
100%
Seroconversion
75%
Titer
50%
Normal Human
25%
Single Drug Dose
25%
Pharmacology, Toxicology and Pharmaceutical Science
Hematologic Malignancy
100%
mRNA Vaccine
100%
Vaccination Policy
22%
Adverse Event
11%
Normal Human
11%
Nonhodgkin Lymphoma
11%
COVID-19 Vaccine
11%